Wave Life Sciences Ltd.
Total Trades
68
Buys
5
Sells
42
Largest Trade
N/A
Insiders
13
Institutional Funds
161
Inst. Value
$1M+
Activist Filings
33
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Francis Chris | See Remarks | EXERCISE | $100K–$500K | 33K | $4.28 | Feb 28, 2026 |
| Francis Chris | See Remarks | SELL | $100K–$500K | 33K | $15.05 | Feb 28, 2026 |
| Moran Kyle | CFO | GRANT | N/A | 46K | — | Feb 12, 2026 |
| Moran Kyle | CFO | SELL | $15K–$50K | 4K | $13.45 | Feb 12, 2026 |
| BOLNO PAUL | President and CEO | SELL | $100K–$500K | 10K | $13.45 | Feb 12, 2026 |
| BOLNO PAUL | President and CEO | GRANT | N/A | 165K | — | Feb 12, 2026 |
| Francis Chris | See Remarks | SELL | $15K–$50K | 2K | $13.45 | Feb 12, 2026 |
| Francis Chris | See Remarks | GRANT | N/A | 39K | — | Feb 12, 2026 |
| Vargeese Chandra | See Remarks | GRANT | N/A | 46K | — | Feb 12, 2026 |
| Vargeese Chandra | See Remarks | SELL | $15K–$50K | 3K | $13.45 | Feb 12, 2026 |
| Francis Chris | See Remarks | EXERCISE | $15K–$50K | 9K | $3.14 | Jan 7, 2026 |
| Francis Chris | See Remarks | SELL | $100K–$500K | 9K | $16.03 | Jan 7, 2026 |
| GSK plc | 10% Owner | BUY | $1M+ | 1.5M | $19.00 | Dec 15, 2025 |
| Rawcliffe Adrian | Director | EXERCISE | $100K–$500K | 42K | $5.97 | Dec 11, 2025 |
| Rawcliffe Adrian | Director | SELL | $500K+ | 42K | $15.00 | Dec 11, 2025 |
| Wagner Heidi L | Director | EXERCISE | $50K–$100K | 14K | $5.97 | Dec 11, 2025 |
| Wagner Heidi L | Director | SELL | $100K–$500K | 14K | $13.50 | Dec 11, 2025 |
| HENRY CHRISTIAN O | Director | SELL | $1M+ | 93K | $14.65 | Dec 11, 2025 |
| HENRY CHRISTIAN O | Director | EXERCISE | $100K–$500K | 87K | $5.07 | Dec 11, 2025 |
| Tan Aik Na | Director | SELL | $1M+ | 134K | $13.58 | Dec 11, 2025 |
| Tan Aik Na | Director | EXERCISE | $500K+ | 119K | $4.85 | Dec 11, 2025 |
| Verdine Gregory L. | Director | SELL | $100K–$500K | 20K | $13.47 | Dec 11, 2025 |
| Francis Chris | See Remarks | EXERCISE | $1M+ | 441K | $4.78 | Dec 11, 2025 |
| Francis Chris | See Remarks | SELL | $1M+ | 441K | $14.57 | Dec 11, 2025 |
| Moran Kyle | CFO | SELL | $1M+ | 260K | $15.78 | Dec 11, 2025 |
| Moran Kyle | CFO | EXERCISE | $1M+ | 296K | $5.20 | Dec 11, 2025 |
| CORRIGAN MARK | Director | SELL | $100K–$500K | 16K | $13.48 | Dec 11, 2025 |
| Rawcliffe Adrian | Director | SELL | $100K–$500K | 16K | $6.79 | Nov 15, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1K–$15K | 1K | $6.69 | Nov 14, 2025 |
| Verdine Gregory L. | Director | SELL | $100K–$500K | 10K | $10.00 | Aug 27, 2025 |
| BOLNO PAUL | President and CEO | SELL | $1M+ | 217K | $10.10 | Aug 27, 2025 |
| Verdine Gregory L. | Director | SELL | $100K–$500K | 30K | $6.95 | Jun 14, 2025 |
| HENRY CHRISTIAN O | Director | EXERCISE | $50K–$100K | 11K | $9.13 | Mar 22, 2025 |
| HENRY CHRISTIAN O | Director | SELL | $100K–$500K | 11K | $9.77 | Mar 22, 2025 |
| BOLNO PAUL | President and CEO | EXERCISE | $100K–$500K | 50K | $2.48 | Nov 28, 2024 |
| BOLNO PAUL | President and CEO | SELL | $500K+ | 50K | $15.00 | Nov 28, 2024 |
| BOLNO PAUL | President and CEO | SELL | $500K+ | 51K | $14.32 | Nov 16, 2024 |
| Francis Chris | See Remarks | SELL | $500K+ | 36K | $16.00 | Nov 14, 2024 |
| Francis Chris | See Remarks | EXERCISE | $100K–$500K | 36K | $8.17 | Nov 14, 2024 |
| Francis Chris | See Remarks | EXERCISE | $100K–$500K | 129K | $2.88 | Oct 19, 2024 |
| Francis Chris | See Remarks | SELL | $1M+ | 209K | $13.67 | Oct 19, 2024 |
| BOLNO PAUL | President and CEO | SELL | $1M+ | 90K | $15.00 | Oct 19, 2024 |
| GSK plc | 10% Owner | BUY | $1M+ | 2.8M | $8.00 | Oct 1, 2024 |
| Moran Kyle | CFO | SELL | $100K–$500K | 17K | $9.00 | Sep 28, 2024 |
| BOLNO PAUL | President and CEO | SELL | $100K–$500K | 48K | $5.78 | Aug 23, 2024 |
| Moran Kyle | CFO | SELL | $50K–$100K | 16K | $6.17 | Apr 6, 2024 |
| GSK plc | 10% Owner | BUY | $1M+ | 3.3M | $5.00 | Jan 30, 2024 |
| Moran Kyle | CFO | SELL | $100K–$500K | 37K | $4.75 | Aug 24, 2023 |
| Vargeese Chandra | See Remarks | SELL | $15K–$50K | 10K | $4.03 | Feb 18, 2023 |
| BOLNO PAUL | President and CEO | SELL | $100K–$500K | 29K | $4.04 | Feb 18, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 161 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| GSK plc | 18.2M | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 18.2M | $1M+ | SH |
| MAVERICK CAPITAL LTD | 9.3M | $1M+ | SH |
| Darwin Global Management, Ltd. | 7.3M | $1M+ | SH |
| M28 Capital Management LP | 5.7M | $1M+ | SH |
| FEDERATED HERMES, INC. | 4.7M | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 4.1M | $1M+ | SH |
| STATE STREET CORP | 3.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 2.7M | $1M+ | SH |
| EMERALD ADVISERS, LLC | 2.5M | $1M+ | SH |
| Siren, L.L.C. | 2.5M | $1M+ | SH |
| PFIZER INC | 1.9M | $1M+ | SH |
| First Light Asset Management, LLC | 1.9M | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 1.7M | $1M+ | SH |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.4M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.0M | $1M+ | SH |
| Squarepoint Ops LLC | 884K | $1M+ | SH |
| VANGUARD GROUP INC | 846K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2026
5.3%
9.8M shares
SC 13G · Feb 5, 2026
8.5%
15.0M shares
SC 13D/A · Dec 15, 2025
13.4%
25.5M shares
SC 13D/A · Nov 14, 2025
14.6%
25.5M shares
Adage Capital Management, L.P.
SC 13G/A · Aug 12, 2025
9.7%
15.0M shares
Adage Capital Management, L.P.
SC 13G/A · May 12, 2025
8.2%
12.5M shares
SC 13G/A · Feb 14, 2025
5.4%
8.3M shares
SC 13G/A · Feb 5, 2025
6.1%
9.4M shares
SC 13G/A · Nov 12, 2024
11.2%
16.8M shares
SC 13G/A · Nov 12, 2024
4.2%
6.2M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
6.7%
9.7M shares
SC 13D/A · Oct 1, 2024
16.0%
25.4M shares
SC 13G/A · Feb 14, 2024
6.9%
8.4M shares
SC 13G/A · Feb 14, 2024
4.7%
5.6M shares
SC 13G/A · Feb 13, 2024
3.7%
4.5M shares
SC 13G/A · Feb 12, 2024
6.0%
7.4M shares
SC 13G/A · Feb 14, 2023
5.2%
4.5M shares
SC 13G/A · Feb 14, 2023
6.9%
6.0M shares
Maverick Capital, Ltd. – 75-2482446
SC 13G/A · Feb 14, 2023
8.2%
7.1M shares
SC 13G/A · Feb 10, 2023
6.8%
5.9M shares
SC 13G · Jan 30, 2023
10.9%
10.7M shares
SC 13G · Dec 22, 2022
6.4%
5.5M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Dec 8, 2022
4.9%
4.2M shares
Shin Nippon Biomedical Laboratories, Ltd.
SC 13D/A · Aug 12, 2022
10.6%
9.6M shares
Kagoshima Shinsangyo Sousei Investment Limited Partnership
SC 13D/A · Jul 20, 2022
3.3%
2.0M shares
SC 13D/A · Jun 21, 2022
20.0%
17.3M shares
SC 13G · May 26, 2022
5.9%
3.6M shares
Maverick Capital, Ltd. – 75-2482446
SC 13G · Feb 14, 2022
9.5%
5.6M shares
Nantahala Capital Management, LLC
SC 13G/A · Feb 14, 2022
1.5%
907K shares
SC 13G/A · Feb 11, 2022
7.8%
4.6M shares
SC 13G/A · Feb 11, 2022
0.9%
553K shares
SC 13G/A · Feb 11, 2022
3.2%
1.9M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 10, 2022
7.8%
4.6M shares